NEO-MACOP-B protocol

Preferred Label : NEO-MACOP-B protocol;

MeSH note : a chemotherapy protocol which includes etoposide and mitoxantrone in addition to MACOP-B with half dose of methotrexate and half administration of doxorubicin; used for the treatment of advanced stage aggressive non-Hodgkin's lymphoma; reduces severe mucositis, a major toxic effect of MACOP-B;

Is substance : O;

Détails

Origin ID

C084218;

UMLS CUI

C0662412;

MeSH term(s) associated for indexing
- antineoplastic combined chemotherapy protocols [MeSH Descriptor]
- bleomycin [MeSH Descriptor]
- cyclophosphamide [MeSH Descriptor]
- doxorubicin [MeSH Descriptor]
- etoposide [MeSH Descriptor]
- methotrexate [MeSH Descriptor]
- mitoxantrone [MeSH Descriptor]
- prednisolone [MeSH Descriptor]
- vincristine [MeSH Descriptor]
Record concept(s)
- NEO-MACOP-B protocol [MeSH concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients